Jianjun Zhang

1989–2026 年に発表

848
論文数
56,609
被引用数
117
h 指数
608
i10 指数

被引用数

Jianjun Zhang の年別被引用数1989 年: 被引用 1 件1990 年: 被引用 6 件1991 年: 被引用 10 件1992 年: 被引用 13 件1993 年: 被引用 12 件1994 年: 被引用 9 件1995 年: 被引用 6 件1996 年: 被引用 8 件1997 年: 被引用 14 件1998 年: 被引用 24 件1999 年: 被引用 25 件2000 年: 被引用 27 件2001 年: 被引用 19 件2002 年: 被引用 23 件2003 年: 被引用 24 件2004 年: 被引用 27 件2005 年: 被引用 36 件2006 年: 被引用 42 件2007 年: 被引用 55 件2008 年: 被引用 49 件2009 年: 被引用 53 件2010 年: 被引用 57 件2011 年: 被引用 66 件2012 年: 被引用 82 件2013 年: 被引用 104 件2014 年: 被引用 151 件2015 年: 被引用 190 件2016 年: 被引用 277 件2017 年: 被引用 376 件2018 年: 被引用 478 件2019 年: 被引用 1,421 件2020 年: 被引用 1,958 件2021 年: 被引用 2,382 件2022 年: 被引用 2,270 件2023 年: 被引用 2,110 件2024 年: 被引用 3,297 件2025 年: 被引用 2,279 件2026 年: 被引用 202 件

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 7,368 件、この内訳の 31.1%アメリカ合衆国: 引用元論文 4,182 件、この内訳の 17.7%イギリス: 引用元論文 1,020 件、この内訳の 4.3%イタリア: 引用元論文 817 件、この内訳の 3.4%ドイツ: 引用元論文 778 件、この内訳の 3.3%インド: 引用元論文 605 件、この内訳の 2.5%フランス: 引用元論文 594 件、この内訳の 2.5%日本: 引用元論文 583 件、この内訳の 2.5%オーストラリア: 引用元論文 582 件、この内訳の 2.5%カナダ: 引用元論文 582 件、この内訳の 2.5%スペイン: 引用元論文 484 件、この内訳の 2%韓国: 引用元論文 471 件、この内訳の 2%
0%31.1%その他 23.7%

分野

  • Medicine39.2%
  • Biochemistry, Genetics and Molecular Biology27.3%
  • Engineering8.8%
  • Computer Science6.7%
  • Immunology and Microbiology3.2%
  • Agricultural and Biological Sciences2.3%
  • その他12.5%

トピック

  • Cancer Immunotherapy and Biomarkers4.2%
  • Lung Cancer Treatments and Mutations3.7%
  • Cancer Genomics and Diagnostics2.7%
  • MicroRNA in disease regulation2%
  • Lung Cancer Research Studies2%
  • Cancer-related molecular mechanisms research1.8%
  • その他83.6%

共著者

全論文

検索で開く
  1. STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brett W. Carter, Jeremy Erasmus, Darragh Halpenny, Andrew J. Plodkowski, Niamh M. Long, Mizuki Nishino, Warren L. Denning, Ana Galán‐Cobo, Haïfa Hamdi, Taghreed Hirz, Pan Tong, Jing Wang, Jaime Rodriguez‐Canales, Pamela Villalobos, Edwin R. Parra, Neda Kalhor, Lynette M. Sholl, Jennifer L. Sauter, Achim A. Jungbluth, Mari Mino–Kenudson, Roxana Azimi, Yasir Y. Elamin, Jianjun Zhang, Giulia C. Leonardi, Fei Jiang, Kwok‐Kin Wong, J. Jack Lee, Vassiliki A. Papadimitrakopoulou, Ignacio I. Wistuba, Vincent A. Miller, Garrett M. Frampton, Jedd D. Wolchok, Alice T. Shaw, Pasi A. Jänne, Philip J. Stephens, Charles M. Rudin, William J. Geese, Lee A. Albacker, John V. Heymach - Cancer Discovery 2018 被引用: 1,604

  2. Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2020 被引用: 687

  3. Co-occurring Genomic Alterations Define Major Subsets of KRAS -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Waun Ki Hong, John D. Minna, James P. Allison, P. Andrew Futreal, Jing Wang, Ignacio I. Wistuba, John V. Heymach - Cancer Discovery 2015 被引用: 916

  4. Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Justin F. Gainor, Matthew D. Hellmann, Mark M. Awad - Journal of Thoracic Oncology 2021 被引用: 367

  5. Structure-based classification predicts drug response in EGFR-mutant NSCLC

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jason B. Cross, Jhanelle E. Gray, John V. Heymach - Nature 2021 被引用: 452

  6. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 1,270

  7. TMSDNet: Transformer with multi-scale dense network for single and multi-view 3D reconstruction

    著者: , , , , , , , , , , - Computer Animation and Virtual Worlds, Comput. Animat. Virtual Worlds 2023 被引用: 103

  8. Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jianjun Zhang, Ferdinandos Skoulidis, Jia Wu, Reza J. Mehran, David C. Rice, Garrett L. Walsh, Wayne L. Hofstetter, Ravi Rajaram, Mara B. Antonoff, Junya Fujimoto, Luisa M. Solis, Edwin R. Parra, Cara Haymaker, Ignacio I. Wistuba, Stephen G. Swisher, Ara A. Vaporciyan, Heather Lin, Jing Wang, Don L. Gibbons, J. Jack Lee, Nadim J. Ajami, Jennifer A. Wargo, James P. Allison, Padmanee Sharma, Humam Kadara, John V. Heymach, Boris Sepesi - Nature Medicine 2023 被引用: 206

  9. Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jing Wang, Blerina Resuli, Lorenza Landi, Shu-Chi Tseng, Mizuki Nishino, Subba R. Digumarthy, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Ara A. Vaporciyan, George R. Blumenschein, Jianjun Zhang, Dwight H. Owen, Collin M. Blakely, Giannis Mountzios, Catherine A. Shu, Christine M. Bestvina, Marina Chiara Garassino, Kristen A. Marrone, Jhanelle E. Gray, Sandip Pravin Patel, Amy L. Cummings, Heather A. Wakelee, Juergen Wolf, Giorgio V. Scagliotti, Federico Cappuzzo, Fabrice Barlési, Pradnya D. Patil, Leylah Drusbosky, Don L. Gibbons, Funda Meric‐Bernstam, J. Jack Lee, John V. Heymach, David S. Hong, Rebecca S. Heist, Mark M. Awad, Ferdinandos Skoulidis - Cancer Discovery 2023 被引用: 181

  10. Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bonnie S. Glisson, Gaurav Singal, Vincent A. Miller, Brian M. Alexander, Garrett M. Frampton, Lee A. Albacker, David S. Shames, Jianjun Zhang, Jianjun Zhang, John V. Heymach - Journal for ImmunoTherapy of Cancer 2021 被引用: 292

  11. Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Cancer 2020 被引用: 372

  12. Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2023 被引用: 224

  13. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 被引用: 1,086

  14. Joint Optimization in Blockchain- and MEC-Enabled Space-Air-Ground Integrated Networks

    著者: , , , , , , - IEEE Internet of Things Journal, IEEE Internet Things J. 2024 被引用: 57

  15. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5

    著者: , , , , , , , , , , - Genome biology 2019 被引用: 462

  16. PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36

    著者: , , , , , , , , , , , , , , , - Circulation 2020 被引用: 274

  17. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2014 被引用: 1,014

  18. Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Adam Wasserstrom, Aharona Shuali, Catherine A. Schnabel, Yuanxin Xi, Lixia Diao, Qi Wang, Jianjun Zhang, Peter Van Loo, Jing Wang, Ignacio I. Wistuba, Lauren A. Byers, John V. Heymach - Cancer Cell 2024 被引用: 112

  19. Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jianjun Zhang, Sheri L. Holmen, Michael T. Tetzlaff, Michael A. Davies - Cancer Discovery 2019 被引用: 347

  20. Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , - Signal Transduction and Targeted Therapy 2022 被引用: 148

  21. Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review

    著者: , , , , , , , , , - International Journal of Molecular Sciences 2023 被引用: 139

  22. Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Amy Spelman, Yasir Y. Elamin, Marcelo V. Negrão, Ferdinandos Skoulidis, Carl M. Gay, Tina Cascone, Mara B. Antonoff, Boris Sepesi, Jeff Lewis, Ignacio I. Wistuba, John D. Hazle, Caroline Chung, David A. Jaffray, Don L. Gibbons, Ara A. Vaporciyan, J Jack Lee, John V. Heymach, Jianjun Zhang, Jia Wu - The Lancet Digital Health 2023 被引用: 109

  23. Large deformation and energy absorption of additively manufactured auxetic materials and structures: A review

    著者: , , - Composites Part B Engineering 2020 被引用: 655

  24. M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma

    著者: , , , , , - Journal of Experimental & Clinical Cancer Research 2018 被引用: 265